Lek to Present Restructuring and Streamlining Plans Today
Ljubljana, 20 January - Pharmaceuticals company Lek, a member of Novartis's generic division Sandoz, is to present the business results for 2005 today, as well as a restructuring and streamlining programme, which is expected to involve job cuts.
The rest of this news item is available to subscribers.
The news item consists of 775 characters (without spaces) or 142 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.